Cian Healthcare Ltd Share Price Live

NSEBSE

₹3.96

(1.80%)

Jul 15, 2025|12:00:00 AM

Invest wise with Expert advice

Equities

Futures

Option

Open₹3.96
Day's High₹3.96
52 Wk High₹23.38
Prev. Close₹3.89
Day's Low₹3.96
52 Wk Low ₹2.97

Turnover (lac)0.15
P/E0
Face Value₹10
Book Value₹16.86
EPS0
Mkt. Cap (Cr.)₹9.9
Div. Yield0

View All Historical Data

No Records Found

View More Options

Cian Healthcare Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

₹3.96

Prev. Close

₹3.89

Turnover(Lac.)

₹0.15

Day's High

₹3.96

Day's Low

₹3.96

52 Week's High

₹23.38

52 Week's Low

₹2.97

Book Value

₹16.86

Face Value

₹10

Mkt Cap (₹ Cr.)

9.9

P/E

EPS

Divi. Yield

Cian Healthcare Ltd Corporate Action

30 Sep 2024

12:00 AM

AGM

Announcement Date: 30 Sep, 2024

3 Jul 2024

12:00 AM

Board Meeting

Agenda : Audited Result

Cian Healthcare Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

Knowledge Center

Demat Account

Trading Account

Cian Healthcare Ltd SHAREHOLDING SNAPSHOT

16 Jul, 2025|06:19 AM

Mar-2025 Sep-2024 Jun-2024 Mar-2024

Foreign Promoter
Indian Promoter
Institutions
Non Institutions
Custodies

Promoter- 27.10%

Foreign: 0.00%

Indian: 27.10%

Non-Promoter- 72.89%

Institutions: 0.00%

Non-Institutions: 72.89%

Custodian: 0.00%

Cian Healthcare Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

ConsolidatedStandalone

GraphTable

Y/e 31 Mar( In .Cr)	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Equity Capital	25	25	25	23.36
Preference Capital	0	0	0	0
Reserves	36.82	36.43	35.35	36.51
Net Worth	61.82	61.43	60.35	59.87
Minority Interest

View Balance Sheet

ConsolidatedStandalone

GraphTable

Y/e 31 Mar( In .Cr)	Mar-2021	Mar-2020	Mar-2019	Mar-2018
Revenue	72.38	57.04	62.44	59.41
yoy growth (%)	26.88	-8.64	5.09	14.74
Raw materials	-42.91	-33.6	-40.42	-36.01
As % of sales	59.28	58.9	64.73	60.61
Employee costs	-6.92	-4.59	-5.62	-4.29

View Profit & Loss

ConsolidatedStandalone

GraphTable

Y/e 31 Mar( In .Cr)	Mar-2021	Mar-2020	Mar-2019	Mar-2018
Profit before tax	0.86	0.07	1.07	5.26
Depreciation	-2.45	-2.45	-2.92	-1.94
Tax paid	-0.33	-0.14	-0.28	-1.25
Working capital	4.97	-5.1	-0.87	14.24
Other operating items

View Cash Flow

ConsolidatedStandalone

GraphTable

Y/e 31 Mar	Mar-2021	Mar-2020	Mar-2019	Mar-2018
Growth matrix (%)
Revenue growth	26.88	-8.64	5.09	14.74
Op profit growth	23.63	-7.39	-37.21	30.48
EBIT growth	20.24	-4.71	-44.86	38.9
Net profit growth	-551.24	-111.05	-83.64	79.07

View Ratios

ConsolidatedStandalone

Select Period

Particulars (Rupees in Crores.)	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Gross Sales	61.7	68.59	77.87	73.73	57.09
Excise Duty	0	0	0	0	0
Net Sales	61.7	68.59	77.87	73.73	57.09
Other Operating Income	0	0	0	0	0
Other Income	0.44	0.73	0.54	0.28	0.86

View Annually Results

Cian Healthcare Ltd Peer Comparison

Company Name	LTP (₹)	P/E (%)	Mkt.Cap (₹Cr.)	NP Qtr (₹Cr.)	Div.Yield (%)	Sales Qtr (₹.Cr)	Book Value (₹)
Sun Pharmaceutical Industries Ltd SUNPHARMA	1,727.7	96.95	4,14,533.1	2,000.46	0.93	7,107.14	101.44
Divis Laboratories Ltd DIVISLAB	6,788.55	81.58	1,80,214.67	667	0.44	2,536	561.08
Cipla Ltd CIPLA	1,490.9	25.02	1,20,427.63	1,485.4	1.07	4,254.47	397.39
Torrent Pharmaceuticals Ltd TORNTPHARM	3,439.55	61.52	1,16,404.77	474	0.17	2,385	224.34
Mankind Pharma Ltd MANKIND	2,652.2	58.1	1,09,463.92	382.46	0	2,126.59	354.71

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

View All Peer Comparision

MORE ABOUT Cian Healthcare Ltd

Management

Register Office

Registrar Office

Managing Director

Suraj Zanwar

Independent Director

Sunil Kumar

Whole Time Director

Santosh Pimparkar

Registered Office

Milkat No 3339 BNo 1 Phursungi,

From Southside CS NO 227/2,

Maharashtra - 412308

Tel: 91-020-26982792

Website: http://www.cian.co

Email: cs@cian.co

Registrar Office

Office No 56-2,

Pinnacle Busine.Park, Mahakali Caves Road,

Mumbai - 400093

Tel: 91-22-62638200

Website: www.bigshareonline.com

Email: investor@bigshareonline.com

Summary

Cian Healthcare Limited was originally incorporated as a Private Limited Company with the name of Cian Healthcare Private Limited on January 07, 2003. Subsequently, the Company was converted into a Pu...
Read More

Reports by Cian Healthcare Ltd

Company FAQs

What is the Cian Healthcare Ltd share price today?

The Cian Healthcare Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹3.96 today.

What is the Market Cap of Cian Healthcare Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Cian Healthcare Ltd is ₹9.90 Cr. as of 15 Jul ‘25

What is the PE and PB ratio of Cian Healthcare Ltd?

The PE and PB ratios of Cian Healthcare Ltd is 0 and 0.23 as of 15 Jul ‘25

What is the 52 Week High and Low of Cian Healthcare Ltd?

The 52-week high/low is the highest and lowest price at which a Cian Healthcare Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Cian Healthcare Ltd is ₹2.97 and ₹23.38 as of 15 Jul ‘25

What is the CAGR of Cian Healthcare Ltd?

Cian Healthcare Ltd's CAGR for 5 Years at -22.86%, 3 Years at -40.76%, 1 Year at -82.25%, 6 Month at 25.71%, 3 Month at 24.92% and 1 Month at -5.71%.

What is the shareholding pattern of Cian Healthcare Ltd?

The shareholding pattern of Cian Healthcare Ltd is as follows:
Promoters - 27.10 %
Institutions - 0.00 %
Public - 72.90 %

QUICKLINKS FOR Cian Healthcare Ltd

Cian Healthcare Ltd Share Price Live

Equities

Futures

Option

Cian Healthcare Ltd KEY RATIOS

Cian Healthcare Ltd Corporate Action

Cian Healthcare Ltd NEWS AND UPDATE

Knowledge Center

Demat Account

Trading Account

Cian Healthcare Ltd SHAREHOLDING SNAPSHOT

Promoter- 27.10%

Non-Promoter- 72.89%

Cian Healthcare Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Cian Healthcare Ltd Peer Comparison

MORE ABOUT Cian Healthcare Ltd

Management

Register Office

Registrar Office

Company FAQs

QUICKLINKS FOR Cian Healthcare Ltd

Information

Financials

Results

News

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES